STAT

Months after a sexual harassment scandal, OrbiMed’s banking another billion

Months after being rocked by sexual harassment allegations, biotech’s largest investment fund is in process of raising $1 billion from investors, its largest offering to date, while the founder who was at the center of the controversy remains a partner at the firm.

Legendary biotech financier Sam Isaly said late last year that he would retire following publication of a STAT investigation in which six former OrbiMed employees said he regularly sexually harassed the firm’s female employees, particularly executive assistants.

But recent filings with the Securities. The Wall Street firm and Isaly are in the process of negotiating his departure, but it’s unclear how long those talks might take.

Você está lendo uma amostra, registre-se para ler mais.

Mais de STAT

STATLeitura de 6 mins
Opinion: The Indian Pharmaceutical Industry Is In Denial Over Drug-quality Charges
If Americans are expecting India to improve the quality of the medicines it makes, they will be waiting a long time for that to happen.
STATLeitura de 4 minsSociety
Opinion: More State Spending On Health Care May Be Eroding Americans’ Health
In many states, investing in communities lags, squeezed aside by increased spending on health care. That sets up a vicious cycle leading to increased rates of premature deaths and costly…
STATLeitura de 4 minsPolitics
Opinion: Economic Barriers To Organ Transplants From Living Donors Must Be Removed
Many people would willingly donate a kidney or part of the liver but can't afford to. It's time to reduce barriers — including economic ones — so anyone who wants…